In vitro test systems and their limitations.
作者信息
Ghallab Ahmed
机构信息
Faculty of Veterinary Medicine, South Valley University, Qena, Egypt.
出版信息
EXCLI J. 2013 Dec 12;12:1024-6. eCollection 2013.
Abstract
摘要
相似文献
1
In vitro test systems and their limitations.
EXCLI J. 2013 Dec 12;12:1024-6. eCollection 2013.
2
The current limitations of in vitro genotoxicity testing and their relevance to the in vivo situation.
Food Chem Toxicol. 2017 Aug;106(Pt B):609-615. doi: 10.1016/j.fct.2016.08.035. Epub 2016 Aug 31.
3
Application, limitations and research requirements of in vitro test systems in toxicology.
Arch Toxicol Suppl. 1986;9:225-36. doi: 10.1007/978-3-642-71248-7_32.
4
Clinical limitations of in vitro testing of microorganism susceptibility.
Am J Hosp Pharm. 1987 Jan;44(1):131-7.
5
Current in vitro methods in nanoparticle risk assessment: limitations and challenges.
Eur J Pharm Biopharm. 2009 Jun;72(2):370-7. doi: 10.1016/j.ejpb.2008.08.009. Epub 2008 Aug 19.
6
Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances.
Integr Environ Assess Manag. 2017 Mar;13(2):302-316. doi: 10.1002/ieam.1862. Epub 2017 Jan 18.
7
The micronucleus test-most widely used genotoxicity test.
Genes Environ. 2016 Oct 1;38:18. doi: 10.1186/s41021-016-0044-x. eCollection 2016.
8
Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.
Expert Opin Drug Metab Toxicol. 2017 Jul;13(7):767-782. doi: 10.1080/17425255.2017.1341489. Epub 2017 Jun 28.
9
A review of in vitro cigarette smoke exposure systems.
Exp Toxicol Pathol. 2013 Nov;65(7-8):1183-93. doi: 10.1016/j.etp.2013.06.001. Epub 2013 Jul 11.
10
Host-pathogen interaction--new in vitro drug test systems against Mycobacterium leprae--possibilities and limitations.
Lepr Rev. 1986;57 Suppl 3:182-200. doi: 10.5935/0305-7518.19860110.
引用本文的文献
1
Cellular Models of Aging and Senescence.
Cells. 2025 Aug 18;14(16):1278. doi: 10.3390/cells14161278.
2
A scoping review and evidence map of radiofrequency field exposure and genotoxicity: assessing , and epidemiological data.
Front Public Health. 2025 Jul 30;13:1613353. doi: 10.3389/fpubh.2025.1613353. eCollection 2025.
3
Innovative horizons: harnessing drug repositioning for targeted therapeutics in colorectal cancer.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 1. doi: 10.1007/s00210-025-04289-3.
4
Myrobalan Fruit Extracts Modulate Immunobiochemical Pathways In Vitro.
Antioxidants (Basel). 2025 Mar 17;14(3):350. doi: 10.3390/antiox14030350.
5
Effects of short- and long-term exercise training on cancer cells in vitro: Insights into the mechanistic associations.
J Sport Health Sci. 2024 Oct 5;14:100994. doi: 10.1016/j.jshs.2024.100994.
6
Inhibition of Metalloproteinases Extends Longevity and Function of In Vitro Human iPSC-Derived Skeletal Muscle.
Biomedicines. 2024 Apr 12;12(4):856. doi: 10.3390/biomedicines12040856.
7
CBD Inhibits In Vivo Development of Human Breast Cancer Tumors.
Int J Mol Sci. 2023 Aug 26;24(17):13235. doi: 10.3390/ijms241713235.
8
Skin Cell and Tissue Responses to Cross-Linked Hyaluronic Acid in Low-Grade Inflammatory Conditions.
Int J Inflam. 2023 Aug 26;2023:3001080. doi: 10.1155/2023/3001080. eCollection 2023.
9
Optomechanically Actuated Hydrogel Platform for Cell Stimulation with Spatial and Temporal Resolution.
ACS Biomater Sci Eng. 2023 Sep 11;9(9):5361-5375. doi: 10.1021/acsbiomaterials.3c00516. Epub 2023 Aug 21.
10
Damage from Carbonated Soft Drinks on Enamel: A Systematic Review.
Nutrients. 2023 Apr 6;15(7):1785. doi: 10.3390/nu15071785.
本文引用的文献
1
Advances in 2D and 3D in vitro systems for hepatotoxicity testing.
EXCLI J. 2013 Nov 28;12:993-6. eCollection 2013.
2
Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration.
Hepatology. 2014 Dec;60(6):2040-51. doi: 10.1002/hep.27136. Epub 2014 May 12.
3
Improving the human hazard characterization of chemicals: a Tox21 update.
Environ Health Perspect. 2013 Jul;121(7):756-65. doi: 10.1289/ehp.1205784. Epub 2013 Apr 19.
4
Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes.
Arch Toxicol. 2013 Feb;87(2):337-45. doi: 10.1007/s00204-012-0999-8. Epub 2012 Dec 29.
5
Developmental neurotoxicity testing with human embryonic stem cell-derived in vitro systems: the novel FP7 ESNATS tests are available.
Arch Toxicol. 2013 Jan;87(1):5-6. doi: 10.1007/s00204-012-0982-4.
6
Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.
Arch Toxicol. 2013 Jan;87(1):123-43. doi: 10.1007/s00204-012-0967-3. Epub 2012 Nov 21.
7
Paradoxical cytotoxicity of tert-butylhydroquinone in vitro: What kills the untreated cells?
Arch Toxicol. 2012 Sep;86(9):1481-7. doi: 10.1007/s00204-012-0841-3. Epub 2012 Mar 31.
8
Interference of engineered nanoparticles with in vitro toxicity assays.
Arch Toxicol. 2012 Jul;86(7):1123-36. doi: 10.1007/s00204-012-0837-z. Epub 2012 Mar 11.
9
Human hepatocytes: isolation, culture, and quality procedures.
Methods Mol Biol. 2012;806:99-120. doi: 10.1007/978-1-61779-367-7_8.
10
Cocaine-induced kidney toxicity: an in vitro study using primary cultured human proximal tubular epithelial cells.
Arch Toxicol. 2012 Feb;86(2):249-61. doi: 10.1007/s00204-011-0749-3. Epub 2011 Oct 8.
Zotero 插件